Duopa NDC 0074-3012

NDC codes

FDA NDC Directory

Product NDC (as listed)0074-3012Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00074-3012Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0074-3012-07	00074301207	7 CARTRIDGE in 1 CARTON (0074-3012-07) / 100 mL in 1 CARTRIDGEMarketed from Jan 15, 2015

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Duopa
Generic name (nonproprietary): carbidopa and levodopa
Active ingredients: Levodopa — 20 mg/mLCarbidopa hydrate — 4.63 mg/mL
Dosage form: Suspension
Route: Enteral
Labeler: AbbVie Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 203952
Marketing start: Jan 15, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Aromatic (Chemical structure)
Identifiers: Product ID 0074-3012_3141c7d9-a3c8-4658-8a14-22182f452465SPL ID 3141c7d9-a3c8-4658-8a14-22182f452465SPL set ID 7066d371-dc6a-0d6f-7bed-e5dd4ee912daRxCUI 1599846, 1599852UNII 46627O600J, MNX7R8C5VOUPC 0300743012071
Pharmacologic class: Aromatic Amino Acid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400074301207 followed by a unit qualifier and the quantity

Package 00074-3012-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 19, 2026.

Indications (excerpt from the label)

DUOPA ® is indicated for the treatment of motor fluctuations in patients with advanced Parkinson’s disease. DUOPA is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in patients with advanced Parkinson’s disease ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)